Wexford Science & Technology and its development partner Ventas, Inc. (NYSE: VTR) today announced a significant investment into 3711 Market Street, one of Philadelphia’s leading multi-tenant life sciences facilities located within the uCity Square Knowledge Community. The 10-story, 150,000 square foot building has long served as a launchpad for some of the city’s most prominent life science companies and their advances in biotech and medicine.
The project, scheduled to be completed in 2025, will update the building’s common areas and lab infrastructure while maintaining its crucial role in supporting the growth of current tenants Eli Lilly and Company (NYSE: LLY), Spark Therapeutics, Inc., and Good Molecules.
The $28.5 million investment will include:
- A renovated building lobby offering contemporary furnishings and a range of seating types designed to facilitate meeting, working, and collaborating among tenants and partners.
- Increased HVAC and back-up power capacity, ensuring the building can meet the evolving demands of today’s complex R&D environments.
- Move-in ready lab and office suites tailored to accommodate a wide range of company needs.
- Capital for future leasing buildouts.
